715
Participants
Start Date
September 30, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
XIAFLEX / XIAPEX
injection (0.58 mg after reconstitution with sterile diluent \[0.3 mg/mL calcium chloride dihydrate in 0.9% sodium chloride\])
Hospital for Special Surgery, New York
SUNY Stony Brook, Setauket
Hand Microsurgery & Reconstructive Orthopaedics, Erie
The Arthritis Clinic of Northern Virginia, PA, Arlington
UNC School of Medicine, Chapel Hill
OrthoCarolina Research Institute, Inc., Charlotte
The Hand and Upper Extremity Center, Atlanta
Alpha Clinical Research, LLC, Clarksville
Christine M. Kleinert Institute for Hand and Microsurgery, Inc., Louisville
Lake Cumberland Rheumatology, Somerset
The Indiana Hand to Shoulder Center, Indianapolis
TRIA Orthopedic Center, Minneapolis
Missoula Bone and Joint, Missoula
Rockford Orthopedic Associates, Rockford
University of Kansas Medical Center, Kansas City
Health Research Institute, Oklahoma City
Accurate Clinical Research, Inc., Houston
HOPE Research Institute, Phoenix
Tucson Orthopaedic Institute, Tucson
Nevada Orthopedic and Spine Center, Las Vegas
CORE Orthopaedic Medical Center, Encinitas
Torrey Pines Medical Group, La Jolla
Brigid Freyne, MD, Inc., Murrieta
The Center for Neurosurgical and Orthopedic Care and Research, Bend
Central Jersey Hand Surgery, Eatontown
Lead Sponsor
Endo Pharmaceuticals
INDUSTRY